Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 44Breast 41Genitourinary 33Other hematologic neoplasm 28Tumor-Agnostic 27Gynecologic 26Other solid neoplasm 25Thoracic 21Head & Neck 17Lymphoid 16Plasma cell 8Other 7Sarcoma 6Dermatologic 6CNS 6Other neoplasm 4Myeloid 4Endocrine 3Classical hematology 1

Conditions

Neoplasms 1Anemia, Sickle Cell 1

Interventions

Cyclophosphamide 94fludarabine phosphate 87Busulfan 64Cyclosporine 57Epoetin Alfa 55Peripheral Blood Stem Cell Transplantation 54Mycophenolic Acid 54Whole-Body Irradiation 53fludarabine 45Antilymphocyte Serum 43Filgrastim 41Cytarabine 41Melphalan 40Tacrolimus 39Darbepoetin alfa 39Methotrexate 34Radiotherapy 33Cord Blood Stem Cell Transplantation 28Granulocyte Colony-Stimulating Factor 23apixaban 22Methylprednisolone 22Rivaroxaban 21Etoposide 21Thiotepa 17Dalteparin 17eltrombopag 16ferric carboxymaltose 14epoetin beta 14Daunorubicin 14Azacitidine 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interviews as Topic × Classical hematology × Clear all
NCT01591187 2015-03-05

The Feasibility of Text Messaging to Assess Secondhand Smoke Exposure Among Youngsters With Cancer or Sickle Cell Disease

St. Jude Children's Research Hospital

Completed
77 enrolled
Classical hematology

Anemia, Sickle Cell, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡